Between 50-75% of patients with Stage 4 colorectal cancer spread to the liver are now living past the five-year mark with the right combination of surgery, chemo and immunotherapy. Hope is real. #TCSC #ColorectalCancer #CancerHope #MetastaticCancer #SurvivalRates

Average 5-year survival rate for all cancers Combined is now up to 70%

Incredibly uplifting news for public health! The average 5-year survival rate for all cancers combined has now reached an inspiring 70% 🥳. This remarkable milestone highlights significant progress in medical science and offers immense hope! #CancerResearch #SurvivalRates #MedicalProgress #Hope

Breakthrough Breast Cancer Pill Extends Survival in 7-Year Trial It's already FDA-approved.

Breakthrough Breast Cancer Pill Extends Survival in 7-Year Trial #Science #HealthandMedicine #Oncology #BreastCancer #CancerResearch #SurvivalRates

NHS introduces new treatment for bladder cancer, significantly improving survival rates The NHS has announced the rollout of a new treatment for advanced bladder cancer that significantly improves survival rates. The combination of two drugs, enfortumab vedotin (Padcev) and pembrolizumab...

NHS introduces new treatment for bladder cancer, significantly improving survival rates killbait.com/en/nhs-intro... #health #bladdercancer #nhstreatment #survivalrates

Opinion | The surprisingly simple treatment that could transform cancer care This low-tech intervention could fundamentally shift how we treat cancer patients.

A new study shows a 37% boost in cancer survival; not from a wonder drug or AI, but a surprisingly simple, low-tech intervention. Sometimes the biggest breakthroughs are the most basic. #TCSC #CancerCare #Oncology #MedicalResearch #SurvivalRates

www.washingtonpost.com/opinions/202...

7/14 The promise is extraordinary: pancreatic cancer has just a 10% survival rate, but in a small study, about half of patients receiving mRNA vaccines saw no cancer return with strong immune responses three years later.
#ExtraordinaryPromise #SurvivalRates

Countries Leading in Cancer Survival Rates: What Makes Them Successful? - OncoDaily Explore how countries like Australia, New Zealand, and the U.S. lead in cancer survival rates, and learn about the key factors that drive their success.

Countries Leading in Cancer Survival Rates: What Makes Them Successful?

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SurvivalRates #CancerSurvival

Citizen Portal News California (@citizenptnewsca.bsky.social) A recent meeting in San Diego revealed a shocking truth: delays in administering life-saving epinephrine during pediatric cardiac arrests could drastically reduce survival rates. Get the details! #SanDiegoCitySanDiegoCounty...

A recent meeting in San Diego revealed a shocking truth: delays in administering life-saving epinephrine during pediatric cardiac arrests could drastically reduce survival rates.

Get the details!

#SanDiegoCitySanDiegoCounty #CA #SurvivalRates #Cit…

Study reveals urgent need for timely epinephrine in pediatric cardiac arrests Delayed epinephrine administration worsens survival rates in pediatric cardiac arrest cases.

A recent meeting in San Diego revealed a shocking truth: delays in administering life-saving epinephrine during pediatric cardiac arrests could drastically reduce survival rates.

Get the details!

#SanDiegoCitySanDiegoCounty #CA #SurvivalRates #CitizenPortal #PediatricHealth #EmergencyResponse

Incidence, Prognostic Factors, and Treatment Impact on Survival in Natural Killer/T-Cell Lymphoma: Population-Based Study in the United States Background: Natural killer (NK)/T-cell lymphoma (NKTL) is a rare malignancy of mature NK/T-cells, predominantly found in Asian and South/Central American populations, with limited studies conducted in Europe and the United States. Objective: The aim of this study is to present an overview of the incidence rate, demographic and clinical characteristics, treatment options, overall survival (OS), and factors influencing OS of NKTL in the United States. Methods: We utilized data from the Surveillance, Epidemiology, and End Results (SEER) 17 database to analyze NKTL cases recorded between 2000 and 2020. In a cohort of 1162 NKTL patients, we calculated the incidence rates and performed statistical analyses to evaluate OS, the effect of radiotherapy and chemotherapy on survival, and lymphoma-specific survival. Results: The mean annual incidence rate of NKTL in the United States was 0.067 per 100,000, with higher rates observed in men compared to women, and an increase noted with age. However, there has been no significant rise in incidence over recent years. Significant racial disparities were observed, with higher incidence rates in Non-Hispanic Asian or Pacific Islanders (NHAPI) and Hispanics. The median survival time for NKTL patients was 21 months, with a 5-year overall survival (OS) rate of 39.5%, which has shown improvement in recent years. Key independent prognostic factors impacting patient survival included age at diagnosis, clinical stage, nasal type presentation, presence of systemic symptoms, and treatment modality. Patients receiving combined radiotherapy and chemotherapy exhibited the best outcomes, with a median OS of 138 months and a 5-year OS rate of 58%. This survival benefit remained consistent even in stage I/localized nasal type patients, achieving a 5-year OS rate of 73.3%. Conclusions: The incidence of NKTL has remained stable in recent years. Patients with the nasal type generally experience better survival outcomes. The use of combined radiotherapy and chemotherapy appears to enhance survival, though further validation through prospective multicenter clinical trials is necessary.

JMIR Formative Res: Incidence, Prognostic Factors, and Treatment Impact on Survival in Natural Killer/T-Cell Lymphoma: Population-Based Study in the United States #NaturalKillerCells #TCellLymphoma #CancerResearch #Oncology #SurvivalRates

Featured today by @MSKLibrary: Evolving racial/ethnic disparities in AML survival in the novel therapy era

#AML #CancerDisparities #EquityInHealthcare #SurvivalRates #OncologyResearch #RacialDisparities #ClinicalOutcomes

ashpublications.org/bloodadvance...

@pennmedicine.bsky.social

Mitazalimab shows promising survival rates in cancer study - PharmaTimes Updated data from phase 2 study reveals survival benefit

#oncology #Mitazalimab #survivalrates #phase2study #survivalbenefit #AlligatorBioscience #phase2clincialtrial #OPTIMIZE1study #combinationtherapy #mFOLFIRINOX #metastaticpancreaticcancer #pancreaticcancer #pancreaticcancerpatients #clinicaltrials #drugdevelopment
pharmatimes.com/news/mitazal...

Physical activity may help colon cancer survivors achieve survival rates similar to the general population – BioNews Central Study indicates that higher levels of physical activity may help colon cancer survivors achieve long-term survival rates comparable to those of the general population. ...

Study indicates that higher levels of #PhysicalActivity may help #ColonCancerSurvivors achieve long-term #SurvivalRates comparable to the general population.
#ColonCancer #ColorectalCancer #CancerRecurrence #Exercise
sbee.link/xnqu6hkt8f

3/5 Key Outcomes:

- Median overall survival: HCC 19.0 months (95% CI, 16.1-22.4); CRLM 10.8 months (95% CI, 8.0-13.5)
- No significant differences in effectiveness, safety, or HRQoL by reimbursement group
- HRQoL stable with some functional and symptom fluctuations.

#SurvivalRates #CancerResearch

Mediterranean Diet: The Secret Weapon Against Melanoma That's Revolutionizing Cancer Treatment Discover how the Mediterranean diet enhances immunotherapy success in melanoma patients, boosts survival rates, and transforms cancer treatment throug

Discover how the Mediterranean diet enhances immunotherapy success in melanoma patients, boosts survival rates, and transforms cancer treatment through gut microbiome optimization.

#MediterraneanDiet #Gut #SurvivalRates #Health #masterchefit

Read www.freeastroscience.com/2025/01/medi...

📈 Survival Trends: Survival probability is higher in males and increases with body length. However, summer survival has increased while winter survival has decreased in recent decades. #SurvivalRates

Precision-guided treatment boosts outcomes in children with high-risk cancers Study reveals that precision-guided treatment (PGT) improves outcomes in high-risk pediatric cancer patients, but clinical adoption remains low due to physician uncertainty and lack of long-term survi...

Precision-guided treatment boosts outcomes in children with high-risk cancers 🎗️🔬🌟 www.news-medical.net/news/2024061... #PrecisionMedicine #Pediatric #Oncology #CancerTreatment #Cancer #TargetedTherapy #PrecisionGuided #SurvivalRates #ChildhoodCancer @natureportfolio.bsky.social

Study finds no significant survival benefit from participating in cancer clinical trials Participation in cancer clinical trials often suggests improved survival rates, but high-quality studies accounting for biases show no significant survival benefit. Trial benefits may be overstated du...

Study finds no significant survival benefit from participating in cancer clinical trials 🔬📊💊 www.news-medical.net/news/2024052... #ClinicalTrials #CancerResearch #SurvivalRates #MedicalResearch #PatientCare #Oncology #Healthcare #EvidenceBased #MetaAnalysis